Action-minimizing periodic orbits of the Lorentz force equation with dominant vector potential
Calculus of Variations and Partial Differential Equations · 2026-06 · 65 (6)
DOI: 10.1007/s00526-026-03350-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calculus of Variations and Partial Differential Equations, online erschienen am 29.04.2026. Verfasst von Manuel Garzón und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación.
Abstract (Originalsprache)
We establish the existence of non-constant periodic solutions to the Lorentz force equation, where no scalar potential is needed to induce the electromagnetic field. Our results extend to cases where a possibly singular scalar potential is present, although the vector potential assumes a leading role. The approach is based on minimizing the action functional associated with the relativistic Lagrangian. The compactness of the minimizing sequences requires the existence of negative values for the functional, which is proven using novel ideas that exploit the sign-indefinite nature of the term involving the vector potential.
Förderung
- Agencia Estatal de Investigación
Zitieren
APA
Garzón, M., & López-Martínez, S. (2026). Action-minimizing periodic orbits of the Lorentz force equation with dominant vector potential. Calculus of Variations and Partial Differential Equations, 65(6). https://doi.org/10.1007/s00526-026-03350-0
Vancouver
Garzón M, López-Martínez S. Action-minimizing periodic orbits of the Lorentz force equation with dominant vector potential. Calculus of Variations and Partial Differential Equations. 2026;65(6). doi:10.1007/s00526-026-03350-0
BibTeX
@article{Garzn2026,
author = {Garzón, Manuel and López-Martínez, Salvador},
title = {Action-minimizing periodic orbits of the Lorentz force equation with dominant vector potential},
journal = {Calculus of Variations and Partial Differential Equations},
year = {2026},
volume = {65},
number = {6},
doi = {10.1007/s00526-026-03350-0}
}
EUVIMED